Cargando…
Functional Versatility of the CDK Inhibitor p57(Kip2)
The cyclin/CDK inhibitor p57(Kip2) belongs to the Cip/Kip family, with p21(Cip1) and p27(Kip1), and is the least studied member of the family. Unlike the other family members, p57(Kip2) has a unique role during embryogenesis and is the only CDK inhibitor required for embryonic development. p57(Kip2)...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575724/ https://www.ncbi.nlm.nih.gov/pubmed/33117811 http://dx.doi.org/10.3389/fcell.2020.584590 |
_version_ | 1783597863577583616 |
---|---|
author | Creff, Justine Besson, Arnaud |
author_facet | Creff, Justine Besson, Arnaud |
author_sort | Creff, Justine |
collection | PubMed |
description | The cyclin/CDK inhibitor p57(Kip2) belongs to the Cip/Kip family, with p21(Cip1) and p27(Kip1), and is the least studied member of the family. Unlike the other family members, p57(Kip2) has a unique role during embryogenesis and is the only CDK inhibitor required for embryonic development. p57(Kip2) is encoded by the imprinted gene CDKN1C, which is the gene most frequently silenced or mutated in the genetic disorder Beckwith–Wiedemann syndrome (BWS), characterized by multiple developmental anomalies. Although initially identified as a cell cycle inhibitor based on its homology to other Cip/Kip family proteins, multiple novel functions have been ascribed to p57(Kip2) in recent years that participate in the control of various cellular processes, including apoptosis, migration and transcription. Here, we will review our current knowledge on p57(Kip2) structure, regulation, and its diverse functions during development and homeostasis, as well as its potential implication in the development of various pathologies, including cancer. |
format | Online Article Text |
id | pubmed-7575724 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75757242020-10-27 Functional Versatility of the CDK Inhibitor p57(Kip2) Creff, Justine Besson, Arnaud Front Cell Dev Biol Cell and Developmental Biology The cyclin/CDK inhibitor p57(Kip2) belongs to the Cip/Kip family, with p21(Cip1) and p27(Kip1), and is the least studied member of the family. Unlike the other family members, p57(Kip2) has a unique role during embryogenesis and is the only CDK inhibitor required for embryonic development. p57(Kip2) is encoded by the imprinted gene CDKN1C, which is the gene most frequently silenced or mutated in the genetic disorder Beckwith–Wiedemann syndrome (BWS), characterized by multiple developmental anomalies. Although initially identified as a cell cycle inhibitor based on its homology to other Cip/Kip family proteins, multiple novel functions have been ascribed to p57(Kip2) in recent years that participate in the control of various cellular processes, including apoptosis, migration and transcription. Here, we will review our current knowledge on p57(Kip2) structure, regulation, and its diverse functions during development and homeostasis, as well as its potential implication in the development of various pathologies, including cancer. Frontiers Media S.A. 2020-10-07 /pmc/articles/PMC7575724/ /pubmed/33117811 http://dx.doi.org/10.3389/fcell.2020.584590 Text en Copyright © 2020 Creff and Besson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Creff, Justine Besson, Arnaud Functional Versatility of the CDK Inhibitor p57(Kip2) |
title | Functional Versatility of the CDK Inhibitor p57(Kip2) |
title_full | Functional Versatility of the CDK Inhibitor p57(Kip2) |
title_fullStr | Functional Versatility of the CDK Inhibitor p57(Kip2) |
title_full_unstemmed | Functional Versatility of the CDK Inhibitor p57(Kip2) |
title_short | Functional Versatility of the CDK Inhibitor p57(Kip2) |
title_sort | functional versatility of the cdk inhibitor p57(kip2) |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575724/ https://www.ncbi.nlm.nih.gov/pubmed/33117811 http://dx.doi.org/10.3389/fcell.2020.584590 |
work_keys_str_mv | AT creffjustine functionalversatilityofthecdkinhibitorp57kip2 AT bessonarnaud functionalversatilityofthecdkinhibitorp57kip2 |